| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
ALKS
Alkermes
|
Jul 20, 2026 | BUY |
Strong Buy
-21.5% avg upside
34 analysts
|
$63.00
21.91% Upside
|
+2.2% |
|
ACAD
ACADIA Pharmaceuticals
|
Jul 20, 2026 | HOLD |
Strong Buy
+42.4% avg upside
43 analysts
|
$25.00
0.40% Downside
|
+0.0% |
|
BIIB
Biogen
|
Jul 14, 2026 | BUY |
Strong Buy
+23.1% avg upside
52 analysts
|
$214.00
6.93% Upside
|
+4.2% |
|
ALNY
Alnylam Pharma
|
Jul 14, 2026 | BUY |
Strong Buy
+27.1% avg upside
51 analysts
|
$444.00
62.74% Upside
|
-3.0% |
|
DFTX
Definium Therapeutics
|
Jul 08, 2026 | BUY |
Strong Buy
+0.8% avg upside
20 analysts
|
$60.00
40.25% Upside
|
-0.5% |
|
CMPS
COMPASS Pathways
|
Jul 08, 2026 | BUY |
Strong Buy
+89.4% avg upside
19 analysts
|
$21.00
80.03% Upside
|
-11.3% |
|
NGNE
Neurogene
|
Jul 06, 2026 | BUY |
Strong Buy
+33.6% avg upside
23 analysts
|
$46.00
23.16% Upside
|
+12.1% |
|
LXEO
Lexeo Therapeutics, Inc.
|
Jul 06, 2026 | BUY |
Strong Buy
+322.5% avg upside
11 analysts
|
$17.00
273.72% Upside
|
-0.9% |
|
VTGN
VistaGen Therapeutics
|
Jul 06, 2026 | HOLD |
Hold
+1025.0% avg upside
8 analysts
|
$1.00
332.64% Upside
|
-8.0% |
|
QURE
uniQure
|
Jun 21, 2026 | BUY |
Strong Buy
+48.5% avg upside
29 analysts
|
$71.00
78.81% Upside
|
-11.3% |
|
RYTM
Rhythm Pharmaceuticals
|
Jun 15, 2026 | BUY |
Strong Buy
+14.2% avg upside
19 analysts
|
$133.00
27.12% Upside
|
+18.8% |
|
SPTX
Seaport Therapeutics, Inc.
|
Jun 09, 2026 | BUY |
Strong Buy
+86.1% avg upside
6 analysts
|
$30.00
46.03% Upside
|
+10.5% |
|
MPLT
MapLight Therapeutics, Inc.
|
Jun 02, 2026 | BUY |
Strong Buy
+10.5% avg upside
13 analysts
|
$36.00
0.04% Downside
|
+38.7% |
|
IMUX
Immunic
|
May 28, 2026 | BUY |
Strong Buy
+149.8% avg upside
21 analysts
|
$25.00
66.63% Upside
|
+0.4% |
|
SION
Sionna Therapeutics, Inc.
|
May 25, 2026 | BUY |
Strong Buy
+16.8% avg upside
11 analysts
|
$55.00
20.36% Upside
|
+9.0% |
|
BMRN
BioMarin Pharmaceutical
|
May 24, 2026 | HOLD |
Strong Buy
+59.3% avg upside
52 analysts
|
$68.00
15.11% Upside
|
+12.7% |
|
RAPP
Rapport Therapeutics, Inc.
|
May 12, 2026 | BUY |
Strong Buy
+34.4% avg upside
13 analysts
|
$56.00
39.28% Upside
|
+8.0% |
|
NMRA
Neumora Therapeutics, Inc.
|
May 12, 2026 | HOLD |
Buy
+370.5% avg upside
11 analysts
|
$3.00
83.97% Upside
|
-15.8% |
|
CTNM
Contineum Therapeutics, Inc. Class A
|
May 08, 2026 | BUY |
Strong Buy
+50.3% avg upside
8 analysts
|
$28.00
106.94% Upside
|
-4.3% |
|
XENE
Xenon
|
May 08, 2026 | BUY |
Strong Buy
-4.9% avg upside
28 analysts
|
$86.00
30.32% Upside
|
+17.0% |
|
NBIX
Neurocrine
|
May 06, 2026 | BUY |
Strong Buy
+2.4% avg upside
37 analysts
|
$188.00
8.60% Upside
|
+16.2% |
|
VRTX
Vertex Pharmaceuticals
|
May 05, 2026 | HOLD |
Strong Buy
-8.2% avg upside
62 analysts
|
$466.00
3.05% Downside
|
+14.4% |
|
IONS
Ionis Pharmaceuticals
|
Apr 30, 2026 | HOLD |
Strong Buy
+50.5% avg upside
43 analysts
|
$86.00
62.49% Upside
|
-26.8% |
|
PEPG
PepGen Inc.
|
Apr 04, 2026 | BUY |
Strong Buy
+382.8% avg upside
9 analysts
|
$12.00
445.50% Upside
|
+34.1% |
|
ANRO
Alto Neuroscience, Inc.
|
Apr 02, 2026 | BUY |
Strong Buy
+16.4% avg upside
13 analysts
|
$33.00
27.44% Upside
|
+19.5% |
|
DNLI
Denali Therapeutics
|
Mar 29, 2026 | BUY |
Strong Buy
+62.9% avg upside
24 analysts
|
$41.00
79.04% Upside
|
+28.8% |
|
LBRX
LB Pharmaceuticals, Inc.
|
Mar 27, 2026 | BUY |
Strong Buy
+44.6% avg upside
8 analysts
|
$40.00
29.43% Upside
|
+31.8% |
|
GHRS
GH Research
|
Mar 06, 2026 | BUY |
Strong Buy
+32.6% avg upside
11 analysts
|
$32.00
16.15% Upside
|
+80.2% |
|
ALEC
Alector
|
Dec 22, 2025 | HOLD |
Buy
+660.1% avg upside
14 analysts
|
— | +3.5% |
|
ABOS
Acumen Pharmaceuticals
|
Dec 16, 2025 | BUY |
Strong Buy
+267.4% avg upside
10 analysts
|
$10.00
352.42% Upside
|
+5.2% |
|
DYN
Dyne Therapeutics
|
Dec 15, 2025 | BUY |
Strong Buy
+62.1% avg upside
30 analysts
|
$36.00
53.50% Upside
|
+22.9% |
|
LONA
LeonaBio
|
Sep 19, 2024 | HOLD |
Buy
+23.2% avg upside
9 analysts
|
— | -16.8% |
|
CLYM
Climb Bio
|
Jun 03, 2023 | BUY |
Strong Buy
+46.7% avg upside
18 analysts
|
$5.00
59.08% Downside
|
+182.7% |
|
WVE
Wave Life Sciences
|
May 12, 2022 | HOLD |
Strong Buy
+287.0% avg upside
28 analysts
|
$3.00
47.64% Downside
|
+207.8% |
|
IRON
Disc Medicine
|
Feb 28, 2022 | HOLD |
Strong Buy
+14.1% avg upside
21 analysts
|
$20.00
73.20% Downside
|
-38.7% |
|
OBSEF
ObsEva
|
Aug 16, 2017 | BUY |
Buy
+1079999900.0% avg upside
8 analysts
|
$18.00
1799999899.91% Upside
|
· |
|
NBRVF
Nabriva Therapeutics
|
Mar 10, 2017 | BUY |
Strong Buy
+13374900.0% avg upside
9 analysts
|
$20.00
19999900.03% Upside
|
· |
|
ACIU
AC Immune SA
|
Nov 23, 2016 | BUY |
Strong Buy
+257.4% avg upside
5 analysts
|
— | -1.4% |
|
FATE
Fate Therapeutics
|
Jun 20, 2016 | BUY |
Buy
+316.0% avg upside
31 analysts
|
— | +49.0% |
|
TBPH
Theravance Biopharma
|
Jun 20, 2016 | BUY |
Buy
+9.5% avg upside
18 analysts
|
$29.00
72.44% Upside
|
+70.2% |
|
TPST
Tempest Therapeutics
|
May 06, 2016 | HOLD |
Buy
+2173.7% avg upside
18 analysts
|
$7.00
634.94% Upside
|
· |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.